Expression of NF-kappaB in rotavirus-induced damage to the liver and biliary tract in neonatal mice

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 2, 2007, Pages 188-193

  Huang, Lei ^a   Gu, Wei Zhong ^b   Si, Xin Min ^c   Wei, Ming Fa ^a   Feng, Jie Xiong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Biliary atresia; NF B; Rotavirus

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BILE DUCT ATRESIA; BILE DUCT INJURY; BILE DUCT OBSTRUCTION; BILIARY TRACT INFLAMMATION; BODY WEIGHT; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISSECTION; FEMALE; GROWTH RATE; HEPATITIS; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INOCULATION; INTRAHEPATIC BILE DUCT; LIVER INJURY; MALE; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ROTAVIRUS; VIROGENESIS; VIRUS CULTURE; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANIMALS, NEWBORN; BILIARY TRACT; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED BALB C; NF-KAPPA B; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 34047272551     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-571.
2. de Zoysa I, Feachem RG. Interventions for the control of diarrhea disease among young children: rotavirus and cholera immunization. Bull World Health Organ 1985;63: 569-583.
3. Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis 1998;4:561-570.
4. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-572.
5. Gilger MA, Matson DO, Conner ME, Rosenblatt HM, Finegold MJ, Estes MK. Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 1992;120:912-917.
6. Buckwold VE, Beer BE, Donis RO. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antivir 2003;60:1-15.
7. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 2001;3:1145-1156.
8. Broor S, Ghosh D, Mathur P. Molecular epidemiology of rotaviruses in India. Indian J Med Res 2003;118:59-67.
9. Lopez S, Arias CF. Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol 2004;12:271-278.
10. Ehrenkranz P, Lanata CF, Penny ME, Salazar-Lin do E, Glass RI. Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings. Rev Panam Salud Publica 2001;10:240-248.
11. Li N, Wang ZY. Viremia and extraintestinal infections in infants with rotavirus diarrhea. Di Yi Jun Yi Da Xue Xue Bao 2003;23:643-648.
12. Eturriza-Gomara M, Auchterlonie IA, Zaw W, Molyneaux P, Desselberger U, Gray J. Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child with CNS disease. J Clin Microbiol 2002;40:4797-4799.
13. Li N, Yao JM. Extraintestinal infection induced by rotavirus. Abroad Medical Science Paidolog Volume 1999;26:253-255.
14. Leonhardt J, Stanulla M, Von Wasielewski R, Skokowa J, Kubler J, Ure BM, et al. Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int 2006;22:84-89.
15. Chiappini E, Azzari C, Moriondo M, Galli L, de Martino MD. Viraemia is a common finding in immunocompetent children with rotavirus infection. J Med Virol 2005;76:265-267.
16. Czech-Schmidt G, Verhagen W, Szavay P, Leonhardt J, Petersen C. Immunological gap in the infectious animal model for biliary atresia. J Surg Res 2001;101:62-67.
17. Mossel EC, Ramig RF. A lymphatic mechanism of rotavirus extraintestinal spread in the neonatal mouse. J Virol 2003; 77:12352-12356.
18. Morris AP, Estes MK. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin. Am J Physiol Gastrointest Liver Physiol 2001; 281:303-310.
19. Riepenhoff-Talty M, Gouves V, Evans MJ, Svensson L, Hoffenberg E, Sokol RJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996;174:8-15.
20. Petersen C, Biermanns D, Kuske M, Schakel K, Meyer-Junghanel L, Mildenberger H. New aspects in a murine model for exreahepatic biliary atresia. J Pediatr Surg 1997;32:1190-1195.
21. Helin E, Vainionpaa R, Hyypia T, Julkunen I, Matikainen S. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 2001;290:1-10.
22. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004; 85:2347-2356.
23. Wang T, Wang Y, Wu MC, Guan XY, Yin ZF. Activating mechanism of transcriptor NF-kappaB regulated by hepatitis B virus X protein in hepatocellular carcinoma. World J Gastroenterol 2004;10:356-360.
24. LaMonica R, Kocer SS, Nazarova J, Dowling W, Geimonen E, shaw RD, et al. VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kB to effect Rotavirus-specific cellular responses. J Biol Chem 2001;276:19889-19896.
25. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G, et al. IRFI042, a novel dual vitamin e-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischemia reperfusion injury. Cardiovasc Res 2000;47:515-528.
26. Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol 2004;10: 22-25.
27. Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 2004;29: 72-79.
28. Liu HS, Pan CE, Liu QG, Yang W, Liu XM. Effects of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J Gastroenterol 2003;9:2513-2518.
29. Santoro MG, Rossi A, Amici C. NF-kappaB and virus infection: who controls whom. EMBO J 2003;22:2552-2560.
30. Yang WJ, Zhang QY, Yu ZP, Song QT, Liang HP, Xu X, et al. Effects of nuclear factor-kappaB on rat hepatocyte regeneration and apoptosis after 70% portal branch ligation. World J Gastroenterol 2005;21:6775-6779.
31. Lentsch AB. Activation and function of hepatocyte NF-kappaB in postischemic liver injury. Hepatology 2005;42: 216-218.
32. Demirbilek S, Akin M, Gurunluoglu K, Aydin NE, Emre MH, Tas E, et al. The NF-κB inhibitors attenuate hepatic injury in bile duct ligated rats. Pediatr Surg Int 2006;22:655-663. Epub 2006 July 8.